Moreover, the detection of increased levels of “systemic” PTX3, like in the urines of BC patients [15], may be the result of the general inflamed milieu generated by and during tumor progression, thus masking the regulatory effect exerted by PTX3 produced by cancer cells. Here, PTX3 is linked to cancer.